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Abstract
Background: Urinary tract infection (UTI) is a widespread infectious disease in humans. Urine culture, a huge
workload in the microbiology laboratory, is still the standard diagnostic test for UTI, but most of the cultures
are negative. A reliable screening method could reduce unnecessary cultures and quicken reporting of negative results.
Methods: We evaluated the usefulness of a flow cytometry (FC) screening method in the prediction of positive urine
culture to reduce the number of urine cultures. The urine specimens sent to the laboratory for culture were tested with
the flow cytometer Accuri C6. FC bacterial counts were compared to standard urine culture results to assess the best
cut-off values.
Results: Two hundred nine urine samples were included, of which 79 (37.8 %) were culture positive. On comparing
the culture and the FC data in the ROC curve, the FC bacterial counts of ≥106 bacteria/mL provided a reliable
screening for bacteriuria with a sensitivity and specificity of 99 and 58 %, respectively. All negative FC results
(<106 bacteria/mL) showed a negative predictive value of 99 % with a negative likelihood ratio of 0.02. The FC
bacterial counts of ≥108/mL showed a positive predictive value of 99 % with a positive likelihood ratio of 60.9.
Conclusions: Counting bacteria in human urine samples by the FC is a fast, accurate and cost-effective screening
method for bacteriuria. Our results showed that FC is able to rule out UTI, which can lead to a substantial reduction
(36 %) of urine cultures. It also demonstrated that this method predicts positive cultures accurately.
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Background
Urinary tract infection (UTI) is one of the most com-
mon infections in humans [1]. Urine culture is still the
standard diagnostic test for UTI in a symptomatic pa-
tient, which additionally provides information about the
pathogen and its antibiotic susceptibility [2]. However, it
is a time-consuming and costly test in which a large
number of cultures are negative.
Urinary dipstick testing for nitrite and leukocyte ester-
ase is the most commonly used test to rule in UTI in
the general practice. It is a fast and cheap method which
can modestly improve diagnostic precision but poorly
rule out UTI [3–5]. Therefore, clinicians have to take
account of the poor negative predictive value (NPV) of
this test and other strategies are needed. Other tech-
niques such as microscopic examination of urine sediment
and Gram-staining may have superior NPV, but are either
subjective or labor-intensive and time-consuming [6–8].
Automated urinalysis by semi-flow cytometry (SFC)
using Sysmex UF-1000i has been described as a fast and
accurate technique to count bacteria in urine samples,
which may result in a reduction of urine culture, labor
and costs [9, 10]. The Sysmex UF-1000i is equipped with
one excitation laser (633 nm) and uses forward scatter
(FSC) and side scatter (SSC) for size and granularity de-
termination plus two fluorescence parameters to detect
bacteria. Flow cytometry (FC) that uses more than one
excitation laser to detect multi fluorescence parameters,
is rapidly becoming a routine methodology in microbial
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studies [11–13]. FC allows the examination of a large
number of cells at a time, recording for each cell several
different parameters that can later be linked to a wide
variety of cellular characteristics [14].
As current tests are moderately reliable and fast, or
more reliable but time-consuming, the urinalysis by FC
could be a good alternative to rule out UTI in clinical
decision making. Therefore, we aimed to assess the pre-
dictive value of FC urine bacterial count to predict posi-
tive and negative cultures. By using the flow cytometer
Accuri C6, we developed a sensitive and rapid FC assay
to quantify the total urine bacterial numbers. We hy-
pothesized that bacteria counting with this technique
could have a high value in the prediction of positive
urine culture compared with regular urinalysis leading
to a fast rule out of UTI. To validate this test we used
the predictive value and compared the FC bacterial
count to urine cultures at different cut-off values of
colony-forming units per mL (CFU/mL). To our know-
ledge, this study is the first one to use FC to identify the
independent predictive value of bacterial counts among
patients with presumed UTI.
Methods
This research was performed at the Department of
Clinical Chemistry of the Isala Hospital in Zwolle,
Netherlands. Urine samples of 209 patients with sus-
pected UTI from general practitioners, outpatient and
clinical departments were collected without any prior se-
lection and sent to the Department of Medical Micro-
biology. Urine samples were then randomly selected and
sent to the clinical chemistry laboratory. At arrival all
consecutive samples were evenly divided over two ali-
quots. One aliquot was used for culture and the other
one was kept at 4 °C and used within 24 h for FC bacter-
ial counting in the clinical chemistry laboratory. The
medical ethical committee of our hospital declared no
objection and informed consent was not needed. The
definition of positive urine cultures in patients with UTI is
still a matter of debate [10], but most often ≥105 CFU/mL
is used to confirm urinary tract infection [4]. We used dif-
ferent cut-off values for positive urine cultures (≥103, ≥104
and ≥105 CFU/mL) to evaluate the results of the FC
analysis. Standard microbiological methods were used
for semi-quantitative determination and identification
of uropathogens [15].
Flowcytometric urinalysis
All urine samples were analysed for bacterial count by
the flow cytometer Accuri C6 (BD Biosciences, USA) in
the clinical chemistry laboratory. The instrument was
validated and maintained daily according to the user
manual. The Accuri C6 is equipped with two excitation
lasers: a blue solid state (488 nm) and a diode red
(640 nm) providing up to 6 simultaneous detection pa-
rameters, including 4 fluorescent colors plus FSC and
SSC. The accuracy of the bacterial counting by the
Accuri C6 was first validated using Trucount-beads
tubes (BD Biosciences, USA) and different dilutions
(10×, 100× and 1000×) of a bacterial strain (Escherichia
coli, ATCC 25922, BD Biosciences, France). The calcu-
lated bacterial counts with beads were compared with
those without beads to evaluate the counting accuracy of
the Accuri C6.
The number of bacteria in human urine samples was
assessed by FC using the following protocol: 5 mL of un-
diluted urine was washed once with staining buffer
(phosphate-buffered saline/0.01 % Tween-20/1 mmol
ethylene-diaminetetraacetic acid (EDTA), both from
Sigma Life Science, USA) and centrifuged (5000 rpm,
5 min at room temperature) to reduce background
noise. The pellet was resuspended in 5 ml staining buffer
and then the washed urine was diluted 1 to 100 with
staining buffer. Subsequently, 500 μl of diluted urine was
added to 500 μl of “pre-diluted” (30000×) SYBR Green
(Life Technologies, Invitrogen) and incubated for 10 min
at 37 °C. SYBR Green (SG) has an excitation/emission
maxima at 494 and 521 nm and binds to DNA of bac-
teria and can therefore be used to count bacteria. Next,
a fixed volume (50 μl) of the urine SG-stained bacterial
cells was analysed on the flow cytometer (Fig. 1) during
5 min using low sample rate and a selected threshold
setting on FSC and SSC to discriminate bacterial cells
from relatively large particles. The instrument threshold
defines the minimum scatter needed to trigger an event
that will be processed by the system software. It allows
not only to reduce the electronic background noise but
also to get rid of the unwanted non-target particles. Par-
ticles with low fluorescence and low SSC have a greater
potential to interfere with the actual determination of
the bacterial density, but these can easily be separated in
the Green fluorescence plot as they do not stain with
SG. Within a few minutes, the absolute amount of bac-
teria per mL could be calculated by multiplying the
amount of counted SG-stained bacteria detected in the
dot plot (gate R3 in Fig. 1) with the conversion factor
(4000×); one representative example is shown in Fig. 1.
Statistical analysis
Statistical analysis was performed using SPSS 22.0 soft-
ware package. FC bacterial counts were compared to bac-
terial urine culture results with a bacteriuria at ≥105 CFU/
ml as most commonly used. In addition, we assessed the
performance of FC counts at different cut-offs. At each
cut-off point we determined the sensitivity, specificity,
positive predictive value (PPV) and negative predictive
value (NPV). Furthermore, positive and negative likeli-
hood ratios (LR+ and LR-) were calculated. LR+ above 10
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or LR- below <0.1 are considered to provide strong evi-
dence to rule in or rule out diagnoses respectively [16].
We used a Receiver Operating Characteristic (ROC) curve
to determine the best cut-off point with highest predictive
rule out value defined by FC analysis. The area under the
receiver operator curve (AUC) is the sum of the highest
sensitivity and specificity and is expressed as mean plus
95 % confidence interval (Cl). Average values for the FC
bacterial counts of the counting method were expressed
as mean ± SEM.
Results
The counting method of the Accuri C6 was validated
using Trucount-beads. The results for counting methods
(with and without beads) were similar: 67,483 ± 4291
(range 65,881–70,230) versus 70,394 ± 4396 (range
68,823–73,321) bacteria/mL with and without beads, re-
spectively (n = 5). The Pearson correlation coefficient
between the two methods was 0.986. So it could be con-
cluded that FC bacterial counting by the Accuri C6 is an
accurate and reliable method to quantify bacteria in
urine samples.
We included different definitions of positive bacterial
culture (≥103, ≥104 and ≥105 CFU/mL) to show the in-
fluence on the sensitivity and specificity of the FFC bac-
terial counting method (Table 1). The diagnostic values
of FC analysis at cut-off value of ≥105 CFU/mL are
summarized in Table 1A. Urine bacterial cultures at FC
cut-off value of ≥105 bacteria/mL were true-positive in
79 samples (38 %). We found 128 false-positive FC
results, in which culture growth was less than 105 CFU/ml
and only 2 samples were true negative at this FC cut-
off point.
At the cut-off point ≥106 in the FC analysis, 78 sam-
ples are true-positive with 55 false-positive (FP) results
while of 76 negative samples only one is false-negative
Fig. 1 FC bacterial counting in urine samples. Bacteria were stained with SYBR Green and measured by the Accuri C6 as outlined in
methods. a-c One representative example of urine bacterial counting. a FSC vs. SSC of bacteria detected in a urine sample (R1). Gate R1
is used in B and C. b FL-1 vs. SSC of an unstained urine sample as a negative control for SYBR Green (SG) staining. R3 gate shows the
background staining (0.1 %). c SG vs. SSC of a stained urine sample. R3 gate shows the amount of SG-stained bacteria present in urine
sample, which is used to calculate the absolute amount of bacteria per mL urine sample
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(FN). Therefore, at this cut-off point sensitivity is 99 %
and specificity is 58 % resulting in a strong NPV of 99 %
and a LR- of 0.02, and this cut-off point essentially rules
out a UTI, while the PPV is 59 %.
A FFC result of 107 or higher showed 9 false-
positives and 14 false-negatives. When using 108 as
cut-off, only one false-positive was found and the rest
of the cultures were true positive, i.e., a PPV of 99 %
and a high LR+ (60.9).
The FC results for other cut-off values for positive
urine culture (≥104 and ≥103 CFU/mL) are shown in
Table 1B and C, respectively. The FC analysis at both
cut-off values for positive urine culture showed a lower
sensitivity than that the FC analysis at higher numbers
of CFU/mL (≥105). The FC cut-off point ≥106 showed a
sensitivity of 90 and 79 % at 104 CFU/mL (Table 1B) and
103 CFU/mL (Table 1C), respectively. In contrast, the
specificities were higher at this FC cut-off point com-
pared with those at ≥105 CFU/mL, i.e., 61 and 74 % at
104 CFU/mL and 103 CFU/mL, respectively.
Based on the FC results, UTI is very unlikely in pa-
tients with lower FC number of bacteria than 106 and
using this cut-off value a urine culture would only have
been done in 133 of the 209 samples (64 %). Cultures
are necessary in patients with a FC bacterial count of
≥107 to confirm bacteriuria and to determine the resist-
ance profile. Bacteriuria is very likely at FC bacterial
count of higher than 108, with a positive predictive value
of 99 % and urine cultures are actually only necessary to
determine the antibiotic resistance profile.
Moreover, we used a ROC-curve to calculate the exact
cut-off point with highest sensitivity and specificity. The
different ROC curves are shown in Fig. 2, showing the
influence of the cut-off value of a positive urine culture
on sensitivity and specificity of the FC bacterial counting
method. Figure 2a shows that the AUC for bacterial de-
tection by the FC method was 0.96 (95 % CI, 0.936–
0.984) at ≥105 CFU/mL. Using ≥105 CFU/mL as cut-off
for positive urine culture, we found a FC bacterial count
of ≥106 bacteria/mL as the best cut-off point for bacteri-
uria with a sensitivity and specificity of 99 % and 58 %.
Using this cut-off value leads to 36 % reduction in urine
cultures, missing only 1.2 % of positive cultures. All
negative FC results (<106 bacteria/mL) showed a nega-
tive predictive value of 99 % with a negative likelihood
ratio of 0.02. The AUCs results for other cut-off values
for positive urine culture (≥104 and ≥103 CFU/mL) are
shown in Fig. 2b and c, respectively. Both cut-off values
for positive urine culture showed a lower AUC value
than the AUC at higher numbers of CFU/mL (≥105).
The AUCs for the FC method were 0.890 (95 % CI,
0,844–0,936) and 0.859 (95 % CI, 0.809–0.908) at ≥104
and ≥103 CFU/mL, respectively.
Discussion
Urinalysis by SFC to detect bacteria has been described
in the literature [9, 10]. However, little has been pub-
lished on the application of FC in UTI diagnostics in
clinical samples. Importantly, a highly sensitive test with
a good NPV is needed in order to prevent unnecessary
urine cultures. If urine cultures could be reduced by
some 36 %, it means that a costs saving could possibly
be achieved.
A survey in the literature about the application of the
SFC Sysmex UF-1000i in bacteriuria screening showed a
calculated sensitivity, specificity and AUC of 92 %, 60 %
and 0.93, respectively [9, 10]. In our study high sensitiv-
ity is accompanied by high AUC (99 % and 0.96, respect-
ively), compared to those found in other recent studies
that evaluated the bacterial detection of the Sysmex UF-
1000i. On the other hand, bacterial counting by this SFC
instrument is automated which prevents mistakes, im-
prove outcomes and simplify analysis [9, 10]. This is an
advantage compared with the Accuri C6, which is not
automated yet.
The definition of positive urine cultures in patients
with UTI is still a matter of debate [10], but most often
≥105 CFU/mL is used as the standard for diagnosis of
UTI in patients with fever [4]. According to the Infec-
tious Diseases Society of America (IDSA) guideline for
uncomplicated UTI, ≥104 CFU/mL can be considered as
cut-off for positive culture [17]. Besides, ≥103 CFU/mL
Table 1 The value of FC urine bacterial count/mL in the
prediction of positive urine culture at different cut-off points
(n = 209)
Cut-off TP FP TN FN Sensitivity Specificity PPV NPV
A (≥105 CFU/mL. n = 79)
≥105 79 128 2 0 100 % 2 % 38 % 100 %
≥106 78 55 75 1 99 % 58 % 59 % 99 %
≥107 65 9 121 14 82 % 93 % 88 % 90 %
≥108 37 1 129 42 47 % 99 % 99 % 75 %
B (≥104 CFU/mL. n = 100)
≥105 100 107 1 1 99 % 1 % 48 % 50 %
≥106 91 42 66 10 90 % 61 % 68 % 87 %
≥107 67 7 101 34 66 % 94 % 91 % 75 %
≥108 37 1 107 64 37 % 99 % 97 % 63 %
C (≥103 CFU/mL. n = 146)
≥105 146 61 0 2 99 % 0 % 71 % 0 %
≥106 117 16 45 31 79 % 74 % 88 % 59 %
≥107 73 1 60 75 49 % 98 % 99 % 44 %
≥108 38 0 61 110 26 % 100 % 100 % 36 %
Diagnostic values when ≥105 CFU/mL (A), ≥104 CFU/mL (B), or ≥103 CFU/mL
(C) was chosen as cut-off value for positive urine cultures
TP true positive, FP false positive, TN true negative, FN false positive, PPV
positive predictive value, NPV negative predictive value
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has been be used as threshold for positive urine cultures
in young women with uncomplicated UTI [18]. Further-
more, ≥103 CFU/mL has been also marked as cut-off for
positive bladder urine culture collected by suprapubic
aspiration and urethral catheterization in patients with
suspected UTI [19]. Although the diagnostic potential of
the Accuri C6 is very high at cut-off value of ≥105 CFU/
mL, it is still quite good at level ≥104 and ≥103 CFU/mL
showing a sensitivity of 90 and 79 %, respectively. In
comparison, at ≥104 and ≥103 CFU/mL showed the Sys-
mex UF-1000i a sensitivity of 82 and 74 %, respectively
[10]. Therefore, most of the clinically relevant infections
can be diagnosed accurately using the Accuri C6. In our
study the FC cut-off point ≥106 essentially ruled out bac-
teriuria. As the FC urinalysis using SG-staining includes
both viable and damaged bacteria, this could possibly ex-
plain the difference between cut-off values (≥105 vs. ≥106)
found by culture and FC methods. Moreover, compared
with the SFC automated method, the application of the
FC method in UTI diagnostics may have additional advan-
tages: The FC instruments contain more than one laser
and they can provide at least 6 simultaneous detection pa-
rameters to measure accurately bacterial cell size, nucleic
acid content and physiological state of each cell. Such
characteristics allow a better resolution of different sub-
populations within the mixed bacterial populations, and
also an easy identification of particles that can interfere
with the counts.
Classical microbiology techniques are relatively slow in
comparison to other analytical techniques, as they
Fig. 2 ROC curves for FC bacterial counting when ≥105 CFU/mL (a), ≥104 CFU/mL (b), or ≥103 CFU/mL (c) was chosen as the definition for
positive urine cultures
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require the isolation of the organism prior to identifica-
tion and other possible testing. In most cases, culture
results are available in 48 to 72 h. Life-threatening in-
fections require prompt antimicrobial therapy and
therefore need rapid and accurate diagnostic tests. FC
allows bacteria detection in clinical samples in a rapid,
flexible, and sensitive way. Bacteria can be identified on
the basis of their peculiar cytometric parameters or by
means of certain fluorochromes. Moreover, when prop-
erly applied, FC can be adjusted to use defined parame-
ters that avoid subjectivity and aid the clinical
microbiologist in the interpretation of specific results,
particularly in the field of rapid diagnosis. Furthermore,
FC devices have become user-friendly, the number of
applications has been expanded, instrument software
has been improved, and costs are gradually decreasing.
However there are also some limitations to this tech-
nique in clinical microbiology laboratories: An import-
ant one is a lack of standardization in FC protocols.
Standards are also lacking in how flow data are ana-
lyzed and reported, because of the massive amount of
data generated. In addition, flow data analysis can be-
come very complicated and relies almost exclusively on
gating by a human expert. Besides, commercial kits to
use this technique in the clinical microbiology labora-
tory are lacking. Finally, to optimize the cost-benefit
ratio of FC in clinical microbiology laboratories, auto-
mation is necessary. This implies adapting flow cyt-
ometers to robotics for automatic sample analysis and
developing software to automate analysis of the results.
Nevertheless, the use of FC in clinical microbiology is
now more than a mere possibility. Today’s universal
presence of flow cytometers should help clinical micro-
biologists to progressively incorporate FC into their
standard protocols.
Conclusion
To the best of the authors’ knowledge, this is the first
study to demonstrate the predictive value of FC, which
is much faster and cost-effective than the gold standard
method, in the diagnostic procedure for UTI. Our result
confirms the potential of FC urine bacterial counts to
predict diagnosis: ‘Ruling out’ bacteriuria, leading to a
substantial reduction of culture and ‘Ruling in’ bacteriuria,
to confirm UTI and define the antibiotic resistance profile
by culture.
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